MAM
ACAD icon

Mark Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Mark Asset Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-59,630
Closed -$1.97M – 55
2015
Q3 		$1.97M Buy
+59,630
New +$2.48M 0.57% 35
2015
Q2 		– Sell
-32,628
Closed -$1.06M – 55
2015
Q1 		$1.06M Sell
32,628
-112,126
-77% -$3.85M 0.28% 42
2014
Q4 		$4.6M Buy
144,754
+44,655
+45% +$1.27M 1.24% 30
2014
Q3 		$2.48M Buy
100,099
+10,622
+12% +$248K 0.68% 37
2014
Q2 		$2.02M Buy
89,477
+53,126
+146% +$1.11M 0.55% 35
2014
Q1 		$885K Buy
+36,351
New +$920K 0.27% 39

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return